However, significant weight loss may alter levothyroxine requirements, and Wegovy's effect on gastric emptying could potentially influence absorption of oral medications, so thyroid function should be monitored regularly
Appetite suppression from both semaglutide and ketosis should now be evident simultaneously
Over-the-counter supplements including herbal preparations, 'fat burners', and appetite suppressants are largely unregulated in terms of clinical efficacy and safety
Although Chinas National Medical Products Administration (NMPA) has yet to approve oral semaglutide, the injection formulation has been included in Chinas national medical insurance since 2021, reimbursing patients 90% of the drug price
Skipping meals while on semaglutide increases hypoglycemia risk because the medication suppresses appetite but still enhances insulin action
This may be attributed to patients gradually adapting to the medication during the treatment process or other factors